Leukemia & Lymphoma
Volume 56, 2015 - Issue 7
Open access
3,972
Views
23
CrossRef citations to date
0
Altmetric
Original Article: Clinical
Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis
Chul Won JungSamsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaCorrespondence[email protected]
, Lee-Yung ShihChang Gung Memorial Hospital-LK and Chang Gung University, Chang Gung, Taiwan
, Zhijian XiaoInstitute of Hematology and Blood Diseases Hospital and State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China
, Jin JieFirst Affiliated Hospital, Zhejiang University College of Medicine, Zhejiang, China
, Hsin-An HouNational Taiwan University Hospital, Taipei, Taiwan
, Xin DuGuangdong General Hospital, Guangdong, China
, Ming-Chung WangChang Gung Memorial Hospital-KS, Kaohsiung, Taiwan
, Seonyang ParkSeoul National University Hospital, Seoul, Korea
, Ki-Seong EomSeoul St Mary's Hospital, The Catholic University of Korea, Seoul, Korea
, Kenji OritaniOsaka University Hospital, Osaka, Japan
, Shinichiro OkamotoKeio University Hospital, Tokyo, Japan
, Tetsuzo TauchiTokyo Medical University Hospital, Tokyo, Japan
, Jin Seok KimYonsei University College of Medicine, Severance Hospital, Seoul, Korea
, Daobin ZhouPeking Union Medical College Hospital, Beijing, China
, Shigeki SaitoNagoya University Hospital, Aichi, Japan
, Junmin LiRuijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
, Hiroshi HandaGunma University Hospital, Gunma, Japan
, Li JianyongJiangsu Province Hospital, Nanjing, China
, Kohshi OhishiMie University Hospital, Mie, Japan
, Ming HouQilu Hospital, Shandong University, Jinan, China
, Wu DepeiThe First Affiliated Hospital of Soochow University, Suzhou, China
, Katsuto TakenakaKyushu University Hospital, Fukuoka, Japan
, Ting LiuWest China Hospital, Sichuan University, Chengdu, China
, Yu HuUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
, Taro AmagasakiNovartis Pharma KK, Tokyo, Japan
, Kazuo ItoNovartis Pharma KK, Tokyo, Japan
, Prashanth GopalakrishnaNovartis Pharma AG, Basel, Switzerland
& Koichi AkashiKyushu University Hospital, Fukuoka, Japan
show all
Pages 2067-2074
|
Received 21 Aug 2014, Accepted 09 Sep 2014, Published online: 20 Nov 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.